000 | 01989 a2200529 4500 | ||
---|---|---|---|
005 | 20250515034922.0 | ||
264 | 0 | _c20061102 | |
008 | 200611s 0 0 eng d | ||
022 | _a0960-894X | ||
024 | 7 |
_a10.1016/j.bmcl.2006.07.031 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmith, Leon | |
245 | 0 | 0 |
_aNovel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cOct 2006 |
||
300 |
_a5102-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 |
_aAzepines _xchemical synthesis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xchemical synthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
700 | 1 | _aWong, Wai C | |
700 | 1 | _aKiselyov, Alexander S | |
700 | 1 | _aBurdzovic-Wizemann, Sabina | |
700 | 1 | _aMao, Yunyu | |
700 | 1 | _aXu, Yongjiang | |
700 | 1 | _aDuncton, Matthew A J | |
700 | 1 | _aKim, Ki | |
700 | 1 | _aPiatnitski, Evgueni L | |
700 | 1 | _aDoody, Jacqueline F | |
700 | 1 | _aWang, Ying | |
700 | 1 | _aRosler, Robin L | |
700 | 1 | _aMilligan, Daniel | |
700 | 1 | _aColumbus, John | |
700 | 1 | _aBalagtas, Chris | |
700 | 1 | _aLee, Sui Ping | |
700 | 1 | _aKonovalov, Andrey | |
700 | 1 | _aHadari, Yaron R | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 16 _gno. 19 _gp. 5102-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2006.07.031 _zAvailable from publisher's website |
999 |
_c16475781 _d16475781 |